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Combating Obesity Through Gut Microbiome
Targeted Phage Therapy
Jeffrey Zhao, Savannah Grossarth, Riley Driscoll, Frances Payne, McKenzie Hatcher, Laura C. Bridgewater
Department of Microbiology and Molecular Biology -- Brigham Young University, Provo, Utah 84602

Background
• Obesity is a serious health issue. In the
U.S. two thirds of adults are overweight
and half are obese. (Ogden, 2012)
• Previous research has shown a correlation
between the gut microbiota and obesity.
• In 2013, by following Koch’s postulates,
researchers isolated Enterobacter cloacae
str. B29 from a morbidly obese patient and
demonstrated that it has the ability to
cause obesity and chronic inflammation in
its host (Fei & Zhao, 2013)

Hypothesis
• Bacteriophages (phage) are viruses that
infect bacteria by binding at specific and
unique binding sites on the cell surface.
• Compared to broad-spectrum antibiotics,
each phage only kills specific bacterium.
Making it possible to only eradicate the
pathogenic bacteria (like B29) in the gut
while leaving the probiotics to flourish,
thus treating obesity.

Results

Summary
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• We conclude that the phages
we have isolated have
promising potential to be
used as a cocktail to
eliminate E. cloacae B29
from the host’s gut, to help
alleviate obesity symptoms.
• We hope that we can pave the
way to more studies on how
phage therapy can treat
other chronic illnesses.

• Thirteen phages were isolated from local sewage plants in Salt Lake and Utah counties.
• Electron microscopy pictures revealed that most of them are in the myoviridae family.
• Lytic activity assays performed with an MOI of 100 showed that many of them are strongly
lytic to E. cloacae B29, suggesting that they could be used to kill B29 bacteria in the gut.
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Future Directions
• Finish genome assembly
and annotation.
• Phage survivability test in
conventional mouse models.
• Phage obesity treatment
test in germ-free mouse
models.
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• Phage genomic DNA was isolated and sequenced on the Illumina platform.
• Preliminary analyses by BLASTn search showed the phages to be 89% - 95% similar to
myoviridae PG7, the most closely related phage in the database, indicating that each one is a
novel, previously uncharacterized phage.
• Genomic dot-plots further strengthen this evidence and also reveal that the new phages are
different from each other.
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